Exchangeable Bond

Fresenius has reduced its stake in dialysis specialist Fresenius Medical Care by 7.2%, holding on to 25% plus one share. CFO Sara Hennicken explains the decision to use a combination of a share sale plus exchangeable bonds, and discusses how the move aligns with the healthcare group's strategy.